Freenome, Inc. (FRNM) vs Health Catalyst, Inc. (HCAT)
A side-by-side comparison of Freenome, Inc. and Health Catalyst, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FRNM
Freenome, Inc.
$17.30HealthcareDelayed quote: Oct 6, 2026, 9:40 AM EDT
HCAT
Health Catalyst, Inc.
$1.78HealthcareDelayed quote: Oct 6, 2026, 9:40 AM EDT
Total return — FRNM vs HCAT
growth of $100 · dividends reinvested · last 1yFRNM +52.9% (+52.9%/yr)HCAT +1.1% (+1.1%/yr)FRNM compounded faster over this window
FRNM HCAT
Metrics side by side
Total return (annualized)
| Metric | FRNM | HCAT |
|---|---|---|
| Total return (1Y) | N/A | -40.39% |
| Total return CAGR (3Y) | N/A | -43.42% |
| Total return CAGR (5Y) | N/A | -48.35% |
FRNM is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.